Meropenem Completed Phase 4 Trials for Bronchiectasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02047773Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations